Accelerating clinical trials takes on special urgency in oncology. Martin Roessner explains how Parexel Biotech is advancing innovative approaches to optimize study design and streamline protocols. He shares that the more flexible the study, the more complex it is. However, even in the case of a biotech company with limited capital, a flexible trial design could confirm efficacy and safety as an early milestone and potentially lead to a second round of financing. Read the full article and be sure to follow the rest of this oncology blog series: https://lnkd.in/gRPwG6EE Learn more about how our dedicated team of Biotech experts will amplify your team's expertise to help you uncover insights faster. #ClinicalResearch #Biotech #Innovation #Oncology #ParexelBiotech
Parexel’s Post
More Relevant Posts
-
For emerging biotechs, there can be endless hurdles in the #oncology clinical development journey. IQVIA Biotech helps to deliver a streamlined end-to-end process across all phases of clinical development. Learn more about our oncology expertise here: https://bit.ly/4bVghyS #oncology #clinicaldevelopment #biotech
To view or add a comment, sign in
-
-
There’s no better time to start your data capture of in vivo oncology, in vitro, and biomarker studies with CrownLink™. Our customer portal is designed to fit your needs with benefits of capturing and monitoring study data without the hassle of a manual process. Experience the benefits of a streamlined workflow today. Register for free https://bit.ly/3tOGXRo #InVitro #InVivo #Oncology #Biomarkers #Biotech #Bioscience
To view or add a comment, sign in
-
Principal - Oncology - Oracle Life Sciences | Consulting | Commercialization | Research | RWE Data & Analytics
⛵️ The Oncology Race in Biotech: Voyage to First Approval ⛵️ Excited to share a fun new infographic! It highlights biotechs nearing their first oncology approval, showcasing their clinical programs and relative timelines. #Oncology #Biotech #ClinicalTrials #oraclelifesciences #cancermpact
To view or add a comment, sign in
-
We wish to thank all our shareholders who attended the Race Oncology 2023 AGM earlier this week, either in person or virtually. During the meeting we provided an important update on our strategy, detailed our new clinical development plans, and explained why we remain extremely positive about our ability to capitalise on bisantrene’s full potential, and ultimately deliver outcomes for patients and our shareholders. For those who were unable to attend, you can access the official Chair’s Address & AGM Presentation, or a recording of the meeting, via the links posted in the comments box below. #biotech #oncology #bisantrene #cardioprotection
To view or add a comment, sign in
-
Don't miss "Operational Strategy: Navigating the development lifecycle," the presentation by Precision's Alexis Hobbins-White at Clinical Operations in Oncology Trials Europe 2023. Learn more about strategic approaches to study planning, opportunities and challenges in biomarker driven "precision medicine," early and late phase oncology and adaptive study designs and strategy, and considerations to support pricing and market access. Tuesday, 28 November at 4:15pm CET #oncology #biomarker #precisionmedicine #marketaccess
To view or add a comment, sign in
-
-
Will you be attending Clinical Operations in Oncology Trials next week, in Munich? Don't miss the following presentation by Alexis Hobbins-White, ''Operational Strategy: Navigating the development lifecycle'' Also, stop by Booth #23 and learn more about Precision's broad clinical reach in the US, EU and APAC! Michael Tarn Angélique Heckmann Precision For Medicine
Don't miss "Operational Strategy: Navigating the development lifecycle," the presentation by Precision's Alexis Hobbins-White at Clinical Operations in Oncology Trials Europe 2023. Learn more about strategic approaches to study planning, opportunities and challenges in biomarker driven "precision medicine," early and late phase oncology and adaptive study designs and strategy, and considerations to support pricing and market access. Tuesday, 28 November at 4:15pm CET #oncology #biomarker #precisionmedicine #marketaccess
To view or add a comment, sign in
-
-
IQVIA Biotech helps you connect the dots in running an #immunooncology clinical trial. With over 140 immuno-oncology clinical trials supported in the last 5 years, IQVIA Biotech has the expertise you need. Explore more IO insights here: https://bit.ly/4fcbjAb #oncology #immunooncology #biotech
To view or add a comment, sign in
-
-
Achieve better workflows and increased productivity for your preclinical study. Say goodbye to manual spreadsheets and hello to a customer portal that saves you time. Now available for in vitro oncology, in vitro, and biomarkers. Get started today ➡️ https://bit.ly/48tlZpR #InVivo #InVitro #Biomarker #Oncology #PreclinicalResearch #CancerResearch #Data #Biotech #Bioscience
CrownLink™ - Meeting your study data needs – one study at a time.
crownbio.com
To view or add a comment, sign in
-
Do you use cell line-derived xenograft (CDX) models in your oncology drug discovery process? 🔬 CDX models can provide key decision-making information to allow an agent to move forward, and to advance preclinical drug development in a timely and cost-effective manner. Discover more ➡️ https://hubs.la/Q02FNS0F0 #Oncology #DrugDiscovery
To view or add a comment, sign in
-
-
While conventional preclinical models struggle to translate study findings to the clinic – resulting in an attrition rate up to 95% for oncology drug development, humanized mouse models generate human-relevant data - accelerating the successful development of novel, safe, and effective treatments. Our guide examines: - Types of mouse model available - The role and application of humanized mouse models in immuno-oncology research - Selecting the most appropriate model for your study design - The benefits of partnering with a preclinical CRO specializing in humanized mouse models Download the guide: https://lnkd.in/ey4T6H5U #PreclinicalStudies #HumanizedMice #DrugDiscovery #DrugDevelopment #Oncology #OncologyResearch #BiomedicalResearch
Guide: Unlock the full potential of your preclinical oncology studies with a humanized mouse model
info.transcurebioservices.com
To view or add a comment, sign in
More from this author
-
Accelerate precision oncology by empowering and educating patients, sites, and physicians
Parexel 6d -
Speeding life-changing medicines to patients by minimizing risk in the preclinical stage
Parexel 1w -
In precision oncology, RWE is especially critical and challenging: Five approaches that work
Parexel 2w
Pharmacovigilance and Clinical Research | Drug Safety Analyst | Technology Enthusiast | Healthcare Data Analytics #pharmacovigilance #dataanalytics #innovation #clinicalresearch #healthcare
1moI agree!